<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">transmed</journal-id><journal-title-group><journal-title xml:lang="ru">Трансляционная медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Translational Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2311-4495</issn><issn pub-type="epub">2410-5155</issn><publisher><publisher-name>Almazov National Medical Research Centre, Saint Petersburg, Russia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/2311-4495-2023-10-3-166-172</article-id><article-id custom-type="elpub" pub-id-type="custom">transmed-851</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭНДОКРИНОЛОГИЧЕСКИЕ ЗАБОЛЕВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>METABOLIC DISEASES</subject></subj-group></article-categories><title-group><article-title>CЛУЧАЙ ВАЗОСПАСТИЧЕСКОЙ СТЕНОКАРДИИ ВСЛЕДСТВИЕ ДЕСТРУКТИВНОГО ТИРЕОТОКСИКОЗА У ПАЦИЕНТА ПОСЛЕ ТРАНСПЛАНТАЦИИ СЕРДЦА</article-title><trans-title-group xml:lang="en"><trans-title>VASOSPASTIC ANGINA DUE TO DESTRUCTIVE THYROTOXICOSIS IN A PATIENT AFTER HEART TRANSPLANTATION: CASE-REPORT</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Циберкин</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Tsiberkin</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Циберкин Александр Иванович, ассистент кафедры эндокринологии, врач-эндокринолог, младший научный сотрудник НИЛ нейроэндокринологии, Институт эндокринологии</p><p>ул. Аккуратова, д. 2, Санкт-Петербург, 197341</p></bio><bio xml:lang="en"><p>Alexander I. Tsiberkin, Assistant of the Department of Endocrinology, Endocrinologist, Junior Researcher, Research Laboratory of Neuroendocrinology, Institute of Endocrinology</p><p>Akkuratova str. 2, Saint Petersburg, 197341</p></bio><email xlink:type="simple">tsibern1@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сазонова</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sazonova</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сазонова Юлия Вячеславовна, ассистент кафедры факультетской терапии, врач-кардиолог, младший научный сотрудник НИЛ кардиоторакальной хирургии</p><p>ул. Аккуратова, д. 2, Санкт-Петербург, 197341</p></bio><bio xml:lang="en"><p>Yuliya V. Sazonova, assistant of the department of faculty therapy, cardiologist, junior researcher, Research Laboratory of Cardiothoracic Surgery</p><p>Akkuratova str. 2, Saint Petersburg, 197341</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Симоненко</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Simonenko</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Симоненко Мария Андреевна, врач-кардиолог, научный сотрудник НИЛ кардиопульмонального тестирования</p><p>ул. Аккуратова, д. 2, Санкт-Петербург, 197341</p></bio><bio xml:lang="en"><p>Maria A. Simonenko, cardiologist, researcher, Research Laboratory for Cardiopulmonary Testing</p><p>Akkuratova str. 2, Saint Petersburg, 197341</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федотов</surname><given-names>П. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedotov</surname><given-names>P. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Федотов Петр Алексеевич, к.м.н., доцент кафедры кардиологии, Институт медицинского образования, ведущий научный сотрудник, заведующий лабораторией высокотехнологичных методов лечения сердечной недостаточности</p><p>ул. Аккуратова, д. 2, Санкт-Петербург, 197341</p></bio><bio xml:lang="en"><p>Petr A. Fedotov, MD, Associate Professor, Department of Cardiology, Institute of Medical Education, Leading Researcher, Head of the Laboratory of High-Tech Methods for the Treatment of Heart Failure</p><p>Akkuratova str. 2, Saint Petersburg, 197341</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Юдина</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Yudina</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юдина Ольга Васильевна, к.м.н., врач-радиолог высшей категории, заведующий отделением радиологии</p><p>ул. Аккуратова, д. 2, Санкт-Петербург, 197341</p></bio><bio xml:lang="en"><p>Olga V. Yudina, MD, Radiologist of the highest category, Head of the Department of Radiology</p><p>Akkuratova str. 2, Saint Petersburg, 197341</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени В. А. Алмазова» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>25</day><month>08</month><year>2023</year></pub-date><volume>10</volume><issue>3</issue><fpage>166</fpage><lpage>172</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Циберкин А.И., Сазонова Ю.В., Симоненко М.А., Федотов П.А., Юдина О.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Циберкин А.И., Сазонова Ю.В., Симоненко М.А., Федотов П.А., Юдина О.В.</copyright-holder><copyright-holder xml:lang="en">Tsiberkin A.I., Sazonova Y.V., Simonenko M.A., Fedotov P.A., Yudina O.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://transmed.almazovcentre.ru/jour/article/view/851">https://transmed.almazovcentre.ru/jour/article/view/851</self-uri><abstract><p>В настоящей работе мы описали клинический случай возникновения вазоспастической стенокардии на фоне развития тиреотоксикоза вследствие применения рентгеноконтрастных йодсодержащих веществ.У пациента 48 лет с болезнью коронарных артерий трансплантированного сердца и достигнутой полной реваскуляризацией после стентирования бассейна передней межжелудочковой артерии возникли и сохранялись эпизоды элевации ST в ночные часы по типу стенокардии Принцметала в отведениях, характеризующих потенциалы передне-перегородочной (V1–V3), передней (V4–V5), боковой (V6, I), нижне-диафрагмальной (III, avF) стенки левого желудочка вне связи с физической нагрузкой, несмотря на оптимальную медикаментозную терапию блокаторами кальциевых каналов и нитратами. При обследовании был выявлен манифестный тиреотоксикоз. У пациента отсутствовали характерные клиническиепризнаки тиреотоксикоза, вероятно, вследствие проводимой иммуносупрессивной терапии, включающей в себя глюкокортикостероиды.На основе преимущественно Т4-тиреотоксикоза, отсутствия повышения антител к рецепторам ТТГ и диффузного снижения накопления 99mТс-пертехнетата по данным сцинтиграфии состояние расценили как деструктивный тиреотоксикоз. После увеличения дозы глюкокортикостероидов был достигнут эутиреоз, на фоне чего эпизоды элевации ST регрессировали.Случай подчеркивает важность своевременного выявления и проведения полноценной дифференциальной диагностики тиреотоксикоза, клиническая картина которого у пациентов с тяжелой сердечно-сосудистой патологией нередко носит атипичный характер. Восстановление нормальной функции щитовидной железы может способствовать регрессу ассоциированных нарушений ритма сердца.</p></abstract><trans-abstract xml:lang="en"><p>In current study, we described the onset of a case of vasospastic angina against the background of thyrotoxicosis.In a 48-year-old patient with transplanted heart coronary artery disease and achieved revascularization after stenting, anterior ventricular failure is used and episodes of ST elevation are preserved in the nighttime indicators of Prinzmetal’s angina in leads characterizing the potentials of the anterior septal (V1–V3), complete anterior (V4–V5), lateral (V6, I), lower diaphragmatic (III, avF) tissue of the left ventricle regardless of physical activity and despite optimal drug therapy with calcium channel blockers and nitrates. The patient did not have characteristic clinical signs of thyrotoxicosis, probably due to ongoing immunosuppressive therapy, in particular, glucocorticosteroids.Destructive thyrotoxicosis was diagnosed due to high T4\T3 ratio, absence of TSH receptor antibodies, and a diffuse decrease of 99mTc-pertechnetate uptake. After increasing the dose of glucocorticosteroids and achieving euthyroid state, the episodes of ST elevation resolved.This case emphasizes the importance of timely detection and proper differential diagnosis of thyrotoxicosis. The clinical course of thyrotoxicosis in patients with severe cardiovascular pathology is often atypical and complicated. Restoration of normal thyroid function may lead to the regression of associated cardiac arrhythmias.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>вазоспастическая стенокардия</kwd><kwd>деструктивный тиреотоксикоз</kwd><kwd>стенокардия Принцметала</kwd><kwd>тиреотоксикоз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>destructive thyrotoxicosis</kwd><kwd>Prinzmetal’s angina</kwd><kwd>thyrotoxicosis</kwd><kwd>vasospastic angina</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Navarro VM. Metabolic regulation of kisspeptin — the link between energy balance and reproduction. Nat Rev Endocrinol. 2020; 16(8):407–420. DOI: 10.1038/s41574-020-0363-7.</mixed-citation><mixed-citation xml:lang="en">Navarro VM. Metabolic regulation of kisspeptin — the link between energy balance and reproduction. Nat Rev Endocrinol. 2020; 16(8):407–420. DOI: 10.1038/s41574-020-0363-7.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Committee opinion no. 605: primary ovarian insufficiency in adolescents and young women. Obstet Gynecol. 2014; 124(1):193–197. DOI: 10.1097/01.AOG.0000451757.51964.98.</mixed-citation><mixed-citation xml:lang="en">Committee opinion no. 605: primary ovarian insufficiency in adolescents and young women. Obstet Gynecol. 2014; 124(1):193–197. DOI: 10.1097/01.AOG.0000451757.51964.98.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tena-Sempere M. Kisspeptin signaling in the brain: recent developments and future challenges. Mol Cell Endocrinol. 2010; 314(2):164–169. DOI: 10.1016/j.mce.2009.05.004.</mixed-citation><mixed-citation xml:lang="en">Tena-Sempere M. Kisspeptin signaling in the brain: recent developments and future challenges. Mol Cell Endocrinol. 2010; 314(2):164–169. DOI: 10.1016/j.mce.2009.05.004.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Avendaño MS, Vazquez MJ, Tena-Sempere M. Disentangling puberty: novel neuroendocrine pathways and mechanisms for the control of mammalian puberty. Hum Reprod Update. 2017; 23(6):737–763. DOI: 10.1093/humupd/dmx025.</mixed-citation><mixed-citation xml:lang="en">Avendaño MS, Vazquez MJ, Tena-Sempere M. Disentangling puberty: novel neuroendocrine pathways and mechanisms for the control of mammalian puberty. Hum Reprod Update. 2017; 23(6):737–763. DOI: 10.1093/humupd/dmx025.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Abreu AP, Kaiser UB. Pubertal development and regulation. Lancet Diabetes Endocrinol. 2016; 4(3):254–264. DOI: 10.1016/S2213-8587(15)00418-0.</mixed-citation><mixed-citation xml:lang="en">Abreu AP, Kaiser UB. Pubertal development and regulation. Lancet Diabetes Endocrinol. 2016; 4(3):254–264. DOI: 10.1016/S2213-8587(15)00418-0.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Acevedo-Rodriguez A, Kauffman AS, Cherrington BD, et al. Emerging insights into hypothalamic-pituitarygonadal axis regulation and interaction with stress signalling. J Neuroendocrinol. 2018; 30(10):e12590. DOI: 10.1111/jne.12590.</mixed-citation><mixed-citation xml:lang="en">Acevedo-Rodriguez A, Kauffman AS, Cherrington BD, et al. Emerging insights into hypothalamic-pituitarygonadal axis regulation and interaction with stress signalling. J Neuroendocrinol. 2018; 30(10):e12590. DOI: 10.1111/jne.12590.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lomniczi A, Ojeda SR. The Emerging Role of Epigenetics in the Regulation of Female Puberty. Endocr Dev. 2016; 29:1–16. DOI: 10.1159/000438840.</mixed-citation><mixed-citation xml:lang="en">Lomniczi A, Ojeda SR. The Emerging Role of Epigenetics in the Regulation of Female Puberty. Endocr Dev. 2016; 29:1–16. DOI: 10.1159/000438840.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Никитина И.Л., Байрамов А.А., Ходулева Ю.Н. и др. Кисспептины в физиологии и патологии полового развития — новые диагностические и терапевтические возможности. Обзоры по клинической фармакологии и лекарственной терапии. 2014; 12(4):3–12. DOI: 10.17816/RCF1243-12.</mixed-citation><mixed-citation xml:lang="en">Nikitina IL, Bayramov AA, Khoduleva YN, et al. Kisspeptins in physiology and pathology of sex development — new diagnostic and therapeutic approaches. Reviews on Clinical Pharmacology and Drug Therapy. 2014; 12(4):3–12.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Latronico AC, Brito VN, Carel JC. Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol. 2016; 4(3):265–274. DOI: 10.1016/S2213-8587(15)00380-0.</mixed-citation><mixed-citation xml:lang="en">Latronico AC, Brito VN, Carel JC. Causes, diagnosis, and treatment of central precocious puberty. Lancet Diabetes Endocrinol. 2016; 4(3):265–274. DOI: 10.1016/S2213-8587(15)00380-0.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Trevisan CM, Montagna E, de Oliveira R, et al. Kisspeptin/GPR54 System: What Do We Know About Its Role in Human Reproduction? Cell Physiol Biochem. 2018; 49(4):1259–1276. DOI: 10.1159/000493406.</mixed-citation><mixed-citation xml:lang="en">Trevisan CM, Montagna E, de Oliveira R, et al. Kisspeptin/GPR54 System: What Do We Know About Its Role in Human Reproduction? Cell Physiol Biochem. 2018; 49(4):1259–1276. DOI: 10.1159/000493406.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Uenoyama Y, Inoue N, Maeda KI, et al. The roles of kisspeptin in the mechanism underlying reproductive functions in mammals. J Reprod Dev. 2018; 64(6):469–476. DOI: 10.1262/jrd.2018-110.</mixed-citation><mixed-citation xml:lang="en">Uenoyama Y, Inoue N, Maeda KI, et al. The roles of kisspeptin in the mechanism underlying reproductive functions in mammals. J Reprod Dev. 2018; 64(6):469–476. DOI: 10.1262/jrd.2018-110.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Vazquez MJ, Velasco I, Tena-Sempere M. Novel mechanisms for the metabolic control of puberty: implications for pubertal alterations in early-onset obesity and malnutrition. J Endocrinol. 2019; 242(2):R51–R65. DOI: 10.1530/JOE-19-0223.</mixed-citation><mixed-citation xml:lang="en">Vazquez MJ, Velasco I, Tena-Sempere M. Novel mechanisms for the metabolic control of puberty: implications for pubertal alterations in early-onset obesity and malnutrition. J Endocrinol. 2019; 242(2):R51–R65. DOI: 10.1530/JOE-19-0223.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Perdices-Lopez C, Avendaño MS, Barroso A, et al. Connecting nutritional deprivation and pubertal inhibition via GRK2-mediated repression of kisspeptin actions in GnRH neurons. Metabolism. 2022; 129:155141. DOI: 10.1016/j.metabol.2022.155141.</mixed-citation><mixed-citation xml:lang="en">Perdices-Lopez C, Avendaño MS, Barroso A, et al. Connecting nutritional deprivation and pubertal inhibition via GRK2-mediated repression of kisspeptin actions in GnRH neurons. Metabolism. 2022; 129:155141. DOI: 10.1016/j.metabol.2022.155141.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Munro MG, Critchley HOD, Fraser IS, et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018; 143(3):393–408. DOI: 10.1002/ijgo.12666.</mixed-citation><mixed-citation xml:lang="en">Munro MG, Critchley HOD, Fraser IS, et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018; 143(3):393–408. DOI: 10.1002/ijgo.12666.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Bhide P, Pundir J, Homburg R, et al. Biomarkers of ovarian reserve in childhood and adolescence: A systematic review. Acta Obstet Gynecol Scand. 2019; 98(5):563–572. DOI: 10.1111/aogs.13574.</mixed-citation><mixed-citation xml:lang="en">Bhide P, Pundir J, Homburg R, et al. Biomarkers of ovarian reserve in childhood and adolescence: A systematic review. Acta Obstet Gynecol Scand. 2019; 98(5):563–572. DOI: 10.1111/aogs.13574.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Navarro DJ, Foxcroft DR. Learning statistics with jamovi: a tutorial for psychology students and other beginners. 2022. (Version 0.75) DOI: 10.24384/hgc3-7p15.</mixed-citation><mixed-citation xml:lang="en">Navarro DJ, Foxcroft DR. Learning statistics with jamovi: a tutorial for psychology students and other beginners. 2022. (Version 0.75) DOI: 10.24384/hgc3-7p15.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ibáñez L, Oberfield SE, Witchel S, et al. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Horm Res Paediatr. 2017; 88(6):371–395. DOI: 10.1159/000479371.</mixed-citation><mixed-citation xml:lang="en">Ibáñez L, Oberfield SE, Witchel S, et al. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Horm Res Paediatr. 2017; 88(6):371–395. DOI: 10.1159/000479371.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Manfredi-Lozano M, Roa J, Tena-Sempere M. Connecting metabolism and gonadal function: Novel central neuropeptide pathways involved in the metabolic control of puberty and fertility. Front Neuroendocrinol. 2018; 48:37–49. DOI: 10.1016/j.yfrne.2017.07.008.</mixed-citation><mixed-citation xml:lang="en">Manfredi-Lozano M, Roa J, Tena-Sempere M. Connecting metabolism and gonadal function: Novel central neuropeptide pathways involved in the metabolic control of puberty and fertility. Front Neuroendocrinol. 2018; 48:37–49. DOI: 10.1016/j.yfrne.2017.07.008.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Никитина И.Л., Юхлина Ю.Н., Васильева Е.Ю. и др. Кисспептиновые механизмы регуляции полового развития мальчиков: потенциал диагностики и терапии при задержке старта пубертата и гипогонадотропном гипогонадизме. Проблемы эндокринологии. 2018; 64(5):280–285. DOI: 10.14341/probl9360.</mixed-citation><mixed-citation xml:lang="en">Nikitina IL, Yuchlina YuN, Vasileva EY, et al. Kisspeptin regulation of male sex development: possibilities of diagnosis and treatment of delayed puberty and hypogonadotropic hypogonadism. Problems of Endocrinology. 2018; 64(5):280–285.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
